title: Complementary and alternative medicine use in patients with hematological cancers in Malaysia.
abstract: BACKGROUND
  Complementary and alternative medicine (CAM) is often used by cancer patients, but not many studies had been published on the prevalence of CAM use in patients with hematological cancers. This study aims to determine the prevalence of CAM and type of CAM used in this group of patients in a multiracial and multicultural country.
  
  
  METHODS
  This is a cross-sectional survey carried out in two hospitals in Malaysia. Patients with underlying hematological cancers were asked to complete the questionnaires on CAM and the Hospital Anxiety and Depression Scale.
  
  
  RESULTS
  A total of 245 patients participated. The prevalence of CAM use was 70.2 %. The most common types of CAM used are biological-based therapies (90.2 %) and mind-body interventions (42 %). Vitamin and diet supplements (68.6 %) and folk/herb remedies (58 %) are the most common biological-based therapies used. There is no significant association of CAM use with age, gender, education level, and household income. Female patients are more likely to use more than one CAM therapies. The most common reason reported for CAM use was to boost immunity (57 %) and cure (24 %). Majority of patients (65 %) felt CAM was effective, and 60 % did not inform their physicians regarding CAM usage.
  
  
  CONCLUSIONS
  In view of the high prevalence of CAM use in patients with hematological cancers, it is important that the physicians play an active role in seeking information from patients and to monitor possible drug-vitamin-herbal interactions.
authors: Department of Medicine, Faculty of Medicine, University Malaya, Lembah Pantai, Kuala Lumpur, 50603, Malaysia, gangg@ummc.edu.my.
authors: G G
authors: GG
authors: Gan
authors: Y C
authors: YC
authors: Leong
authors: P C
authors: PC
authors: Bee
authors: E
authors: E
authors: Chin
authors: A K H
authors: AK
authors: Teh
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000529:Complementary Therapies / Q000379:methods*; D003430:Cross-Sectional Studies; D005260:Female; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D008296:Malaysia; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011795:Surveys and Questionnaires; D055815:Young Adult